{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:01:04Z","timestamp":1776510064572,"version":"3.51.2"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003037","name":"Elan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["C12\/BM\/3976013"],"award-info":[{"award-number":["C12\/BM\/3976013"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["C13\/BM\/5782168"],"award-info":[{"award-number":["C13\/BM\/5782168"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["I1R-BICPFN- 15NCER"],"award-info":[{"award-number":["I1R-BICPFN- 15NCER"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Understanding Parkinson\u2019s disease (PD), in particular in its earliest phases, is important for diagnosis and treatment. However, human brain samples are collected post-mortem, reflecting mainly end-stage disease. Because brain samples of mouse models can be collected at any stage of the disease process, they are useful in investigating PD progression. Here, we compare ventral midbrain transcriptomics profiles from\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein transgenic mice with a progressive, early PD-like striatal neurodegeneration across different ages using pathway, gene set, and network analysis methods. Our study uncovers statistically significant altered genes across ages and between genotypes with known, suspected, or unknown function in PD pathogenesis and key pathways associated with disease progression. Among those are genotype-dependent alterations associated with synaptic plasticity and neurotransmission, as well as mitochondria-related genes and dysregulation of lipid metabolism. Age-dependent changes were among others observed in neuronal and synaptic activity, calcium homeostasis, and membrane receptor signaling pathways, many of which linked to G-protein coupled receptors. Most importantly, most changes occurred before neurodegeneration was detected in this model, which points to a sequence of gene expression events that may be relevant for disease initiation and progression. It is tempting to speculate that molecular changes similar to those changes observed in our model happen in midbrain dopaminergic neurons before they start to degenerate. In other words, we believe we have uncovered molecular changes that accompany the progression from preclinical to early PD.\n                  <\/jats:p>","DOI":"10.1007\/s12035-020-02085-z","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T02:02:41Z","timestamp":1601431361000},"page":"576-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A New Synuclein-Transgenic Mouse Model for Early Parkinson\u2019s Reveals Molecular Features of Preclinical Disease"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-4307","authenticated-orcid":false,"given":"Diana M.","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Sciortino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher J.","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-8676","authenticated-orcid":false,"given":"Heike","family":"Kollmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Kaoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Vallar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1805-0279","authenticated-orcid":false,"given":"Manuel","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Glaab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"6794","key":"2085_CR1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35019019","volume":"406","author":"R Albert","year":"2000","unstructured":"Albert R, Jeong H, Barab\u00e1si AL (2000) Error and attack tolerance of complex networks. Nature 406(6794):378","journal-title":"Nature"},{"issue":"23","key":"2085_CR2","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PM Antony","year":"2013","unstructured":"Antony PM, Diederich NJ, Kr\u00fcger R, Balling R (2013) The hallmarks of Parkinson\u2019s disease. The FEBS journal 280(23):5981\u20135993","journal-title":"The FEBS journal"},{"issue":"4","key":"2085_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pbb.2010.03.009","volume":"95","author":"E Antzoulatos","year":"2010","unstructured":"Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI (2010) Sex differences in motor behavior in the MPTP mouse model of Parkinson\u2019s disease. Pharmacology Biochemistry and Behavior 95(4):466\u2013472","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"2085_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.01.016","volume":"89","author":"L Arcuri","year":"2016","unstructured":"Arcuri L, Viaro R, Bido S, Longo F, Calcagno M, Fernagut PO, Zaveri NT, Cal\u00f3 G, et al. (2016) Genetic and pharmacological evidence that endogenous nociceptin\/orphanin FQ contributes to dopamine cell loss in Parkinson\u2019s disease. Neurobiology of disease 89:55\u201364","journal-title":"Neurobiology of disease"},{"key":"2085_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neurobiolaging.2017.06.008","volume":"58","author":"A Ashrafi","year":"2017","unstructured":"Ashrafi A, Garcia P, Kollmus H, Schughart K, Del Sol A, Buttini M, Glaab E (2017) Absence of regulator of G-protein signaling 4 does not protect against dopamine neuron dysfunction and injury in the mouse 6-hydroxydopamine lesion model of Parkinson\u2019s disease. Neurobiology of aging 58:30\u201333","journal-title":"Neurobiology of aging"},{"issue":"1","key":"2085_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33117","volume":"6","author":"A Baumuratov","year":"2016","unstructured":"Baumuratov A, Antony P, Ostaszewski M, He F, Salamanca L, Antunes L, Weber J, Longhino L, et al. (2016) Enteric neurons from Parkinson\u2019s disease patients display ex vivo aberrations in mitochondrial structure. Scientific reports 6(1):1\u201312","journal-title":"Scientific reports"},{"issue":"1","key":"2085_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal statistical society: series B (Methodological) 57(1):289\u2013300","journal-title":"Journal of the Royal statistical society: series B (Methodological)"},{"issue":"3","key":"2085_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nbd.2008.05.006","volume":"31","author":"R Betarbet","year":"2008","unstructured":"Betarbet R, Anderson LR, Gearing M, Hodges TR, Fritz JJ, Lah JJ, Levey AI (2008) Fas-associated factor 1 and Parkinson\u2019s disease. Neurobiology of disease 31(3):309\u2013315","journal-title":"Neurobiology of disease"},{"issue":"4","key":"2085_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","volume":"26","author":"E Bezard","year":"2003","unstructured":"Bezard E, Gross CE, Brotchie JM (2003) Presymptomatic compensation in Parkinson\u2019s disease is not dopamine-mediated. Trends in neurosciences 26(4):215\u2013221","journal-title":"Trends in neurosciences"},{"key":"2085_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","volume":"298","author":"J Blesa","year":"2017","unstructured":"Blesa J, Trigo-Damas I, Dileone M, del Rey NLG, Hernandez LF, Obeso JA (2017) Compensatory mechanisms in Parkinson\u2019s disease: circuits adaptations and role in disease modification. Experimental neurology 298:148\u2013161","journal-title":"Experimental neurology"},{"key":"2085_CR11","doi-asserted-by":"crossref","unstructured":"Blumenberg M (2019) Introductory chapter: transcriptome analysis. In: Transcriptome analysis. InTechOpen, London,UK","DOI":"10.5772\/intechopen.85980"},{"issue":"10","key":"2085_CR12","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms19102973","volume":"19","author":"A Bohush","year":"2018","unstructured":"Bohush A, Niewiadomska G, Filipek A (2018) Role of mitogen activated protein kinase signaling in Parkinson\u2019s disease. International journal of molecular sciences 19(10):2973","journal-title":"International journal of molecular sciences"},{"issue":"22","key":"2085_CR13","doi-asserted-by":"crossref","first-page":"31,955","DOI":"10.18632\/oncotarget.7454","volume":"7","author":"S Bougnaud","year":"2016","unstructured":"Bougnaud S, Golebiewska A, Oudin A, Keunen O, Harter PN, M\u00e4der L., Azuaje F, Fritah S, et al. (2016) Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget 7(22):31,955","journal-title":"Oncotarget"},{"issue":"2","key":"2085_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","volume":"30","author":"M Bourque","year":"2009","unstructured":"Bourque M, Dluzen DE, Di Paolo T (2009) Neuroprotective actions of sex steroids in Parkinson\u2019s disease. Frontiers in neuroendocrinology 30(2):142\u2013157","journal-title":"Frontiers in neuroendocrinology"},{"issue":"40","key":"2085_CR15","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.1697-05.2005","volume":"25","author":"M Buttini","year":"2005","unstructured":"Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, et al. (2005) \u03b2-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer\u2019s disease. J Neurosci 25(40):9096\u2013 9101","journal-title":"J Neurosci"},{"issue":"1","key":"2085_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1326-6-83","volume":"6","author":"Y Cabeza-Arvelaiz","year":"2011","unstructured":"Cabeza-Arvelaiz Y, Fleming SM, Richter F, Masliah E, Chesselet MF, Schiestl RH (2011) Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons. Molecular neurodegeneration 6(1):83","journal-title":"Molecular neurodegeneration"},{"issue":"5","key":"2085_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2015.08.002","volume":"162","author":"C Cang","year":"2015","unstructured":"Cang C, Aranda K, Seo YJ, Gasnier B, Ren D (2015) TMEM175 is an organelle K+ channel regulating lysosomal function. Cell 162(5):1101\u20131112","journal-title":"Cell"},{"issue":"3","key":"2085_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","volume":"26","author":"I Cantuti-Castelvetri","year":"2007","unstructured":"Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG (2007) Effects of gender on nigral gene expression and parkinson disease. Neurobiology of disease 26(3):606\u2013614","journal-title":"Neurobiology of disease"},{"issue":"4","key":"2085_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2014what are the challenges? Nature reviews Drug discovery 12(4):265","journal-title":"Nature reviews Drug discovery"},{"issue":"33","key":"2085_CR20","doi-asserted-by":"crossref","first-page":"23,818","DOI":"10.1074\/jbc.M701078200","volume":"282","author":"IH Cheng","year":"2007","unstructured":"Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puoliv\u00e4li J, Lesn\u00e9 S, et al. (2007) Accelerating amyloid-\u03b2 fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. Journal of Biological Chemistry 282(33):23,818\u201323,828","journal-title":"Journal of Biological Chemistry"},{"issue":"42","key":"2085_CR21","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","volume":"25","author":"J Chin","year":"2005","unstructured":"Chin J, Palop JJ, Puoliv\u00e4li J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, et al. (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 25(42):9694\u20139703","journal-title":"J Neurosci"},{"issue":"4","key":"2085_CR22","first-page":"455","volume":"9","author":"S D Skaper","year":"2010","unstructured":"D Skaper S, Giusti P (2010) Transgenic mouse models of Parkinson\u2019s disease and Huntington\u2019s disease. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 9(4):455\u2013470","journal-title":"CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"4","key":"2085_CR23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1471-4159.1991.tb11402.x","volume":"56","author":"J De Keyser","year":"1991","unstructured":"De Keyser J, De Backer JP, Vauquelin G, Ebinger G (1991) D1 and d2 dopamine receptors in human substantia nigra: localization and the effect of aging. Journal of neurochemistry 56(4):1130\u20131133","journal-title":"Journal of neurochemistry"},{"issue":"8","key":"2085_CR24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, et al. (2008) Incidental Lewy body disease and preclinical Parkinson disease. Archives of neurology 65(8):1074\u20131080","journal-title":"Archives of neurology"},{"issue":"7","key":"2085_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng.3589","volume":"48","author":"HX Deng","year":"2016","unstructured":"Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, et al. (2016) Identification of TMEM230 mutations in familial Parkinson\u2019s disease. Nature genetics 48(7):733","journal-title":"Nature genetics"},{"issue":"19","key":"2085_CR26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/WNL.0b013e318236ef60","volume":"77","author":"P Derkinderen","year":"2011","unstructured":"Derkinderen P, Rouaud T, Lebouvier T, Des Varannes SB, Neunlist M, De Giorgio R (2011) Parkinson disease: the enteric nervous system spills its guts. Neurology 77(19):1761\u20131767","journal-title":"Neurology"},{"key":"2085_CR27","doi-asserted-by":"crossref","unstructured":"Deutch A (2006) Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson\u2019s disease. In: Parkinson\u2019s disease and related disorders, pp. 67\u201370. Springer","DOI":"10.1007\/978-3-211-45295-0_12"},{"key":"2085_CR28","doi-asserted-by":"crossref","first-page":"e40,202","DOI":"10.7554\/eLife.40202","volume":"7","author":"HS Dhekne","year":"2018","unstructured":"Dhekne HS, Yanatori I, Gomez RC, Tonelli F, Diez F, Sch\u00fcle B., Steger M, Alessi DR, et al. (2018) A pathway for Parkinson\u2019s disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain. Elife 7:e40,202","journal-title":"Elife"},{"issue":"4","key":"2085_CR29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, et al. (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta neuropathologica 115(4):437\u2013444","journal-title":"Acta neuropathologica"},{"key":"2085_CR30","doi-asserted-by":"crossref","unstructured":"Dijkstra AA, Ingrassia A, de Menezes RX, van Kesteren RE, Rozemuller AJ, Heutink P, Van de Berg WD (2015) Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson\u2019s disease PloS one 10(6)","DOI":"10.1371\/journal.pone.0128651"},{"issue":"11","key":"2085_CR31","doi-asserted-by":"crossref","first-page":"E2253","DOI":"10.1073\/pnas.1616892114","volume":"114","author":"AR Dunn","year":"2017","unstructured":"Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, et al. (2017) Synaptic vesicle glycoprotein 2C (SV2c) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences 114(11):E2253\u2013E2262","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"2085_CR32","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.yexcr.2008.02.019","volume":"314","author":"LC Edman","year":"2008","unstructured":"Edman LC, Mira H, Arenas E (2008) The \u03b2-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons. Experimental cell research 314(10):2123\u20132130","journal-title":"Experimental cell research"},{"issue":"3","key":"2085_CR33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","volume":"26","author":"A Esposito","year":"2007","unstructured":"Esposito A, Dohm CP, Kermer P, B\u00e4hr M, Wouters FS (2007) \u03b1-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton. Neurobiology of disease 26(3):521\u2013531","journal-title":"Neurobiology of disease"},{"issue":"4","key":"2085_CR34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7(4):306\u2013318","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2085_CR35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/brain\/113.6.1823","volume":"113","author":"J Fearnley","year":"1990","unstructured":"Fearnley J, Lees A (1990) Striatonigral degeneration: a clinicopathological study. Brain 113 (6):1823\u20131842","journal-title":"Brain"},{"issue":"1","key":"2085_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12035-013-8489-4","volume":"49","author":"KA Fujita","year":"2014","unstructured":"Fujita KA, Ostaszewski M, Matsuoka Y, Ghosh S, Glaab E, Trefois C, Crespo I, Perumal TM, et al. (2014) Integrating pathways of Parkinson\u2019s disease in a molecular interaction map. Molecular neurobiology 49(1):88\u2013102","journal-title":"Molecular neurobiology"},{"issue":"7","key":"2085_CR37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/nan.12221","volume":"41","author":"P Garcia-Esparcia","year":"2015","unstructured":"Garcia-Esparcia P, Hern\u00e1ndez-Ortega K, Ansoleaga B, Carmona M, Ferrer I (2015) Purine metabolism gene deregulation in Parkinson\u2019s disease. Neuropathology and applied neurobiology 41 (7):926\u2013940","journal-title":"Neuropathology and applied neurobiology"},{"issue":"8","key":"2085_CR38","doi-asserted-by":"crossref","first-page":"e71,634","DOI":"10.1371\/journal.pone.0071634","volume":"8","author":"SJ Gardai","year":"2013","unstructured":"Gardai SJ, Mao W, Sch\u00fcle B, Babcock M, Schoebel S, Lorenzana C, Alexander J, Kim S, et al. (2013) Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson\u2019s disease. PloS one 8(8):e71,634","journal-title":"PloS one"},{"issue":"10","key":"2085_CR39","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome biology 5(10):R80","journal-title":"Genome biology"},{"issue":"6","key":"2085_CR40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ane.12796","volume":"136","author":"D Georgiev","year":"2017","unstructured":"Georgiev D, Hamberg K, Hariz M, Forsgren L, Hariz GM (2017) Gender differences in Parkinson\u2019s disease: a clinical perspective. Acta Neurol Scand 136(6):570\u2013584","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"2085_CR41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tins.2012.06.008","volume":"35","author":"AH Gittis","year":"2012","unstructured":"Gittis AH, Kreitzer AC (2012) Striatal microcircuitry and movement disorders. Trends in neurosciences 35(9):557\u2013564","journal-title":"Trends in neurosciences"},{"issue":"8","key":"2085_CR42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, et al. (2007) Gender differences in Parkinson\u2019s disease. Journal of Neurology Neurosurgery & Psychiatry 78(8):819\u2013824","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"},{"key":"2085_CR43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2014.10.010","volume":"263","author":"P Hadaczek","year":"2015","unstructured":"Hadaczek P, Wu G, Sharma N, Ciesielska A, Bankiewicz K, Davidow AL, Lu ZH, Forsayeth J, et al. (2015) GDNF signaling implemented by GM1 ganglioside; failure in Parkinson\u2019s disease and GM1-deficient murine model. Experimental neurology 263:177\u2013189","journal-title":"Experimental neurology"},{"issue":"3","key":"2085_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2004.6.3\/ahartmann","volume":"6","author":"A Hartmann","year":"2004","unstructured":"Hartmann A (2004) Postmortem studies in Parkinson\u2019s disease. Dialogues in clinical neuroscience 6(3):281","journal-title":"Dialogues in clinical neuroscience"},{"issue":"8","key":"2085_CR45","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1523\/JNEUROSCI.4564-03.2004","volume":"24","author":"S Hayley","year":"2004","unstructured":"Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, et al. (2004) Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson\u2019s disease. J Neurosci 24(8):2045\u20132053","journal-title":"J Neurosci"},{"issue":"6","key":"2085_CR46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/mds.27349","volume":"33","author":"S Heinzel","year":"2018","unstructured":"Heinzel S, Kasten M, Behnke S, Vollstedt EJ, Klein C, Hagenah J, Pausch C, Heilmann R, et al. (2018) Age-and sex-related heterogeneity in prodromal Parkinson\u2019s disease. Mov Disord 33 (6):1025\u20131027","journal-title":"Mov Disord"},{"issue":"5","key":"2085_CR47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.10324","volume":"52","author":"AA Hicks","year":"2002","unstructured":"Hicks AA, P\u00e9tursson H, J\u00f3nsson T, Stef\u00e1nsson H, J\u00f3hannsd\u00f3ttir HS, Sainz J, Frigge ML, Kong A, et al. (2002) A susceptibility gene for late-onset idiopathic Parkinson\u2019s disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 52(5):549\u2013 555","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"4","key":"2085_CR48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? The Lancet Neurology 8(4):382\u2013397","journal-title":"The Lancet Neurology"},{"issue":"4","key":"2085_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46(4):292\u2013300","journal-title":"Neuroepidemiology"},{"issue":"4","key":"2085_CR50","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1523\/JNEUROSCI.5175-08.2009","volume":"29","author":"CCY Ho","year":"2009","unstructured":"Ho CCY, Rideout HJ, Ribe E, Troy CM, Dauer WT (2009) The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci 29(4):1011\u20131016","journal-title":"J Neurosci"},{"issue":"2","key":"2085_CR51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, et al. (2015) Orchestrating high-throughput genomic analysis with Bioconductor. Nature methods 12(2):115","journal-title":"Nature methods"},{"issue":"39","key":"2085_CR52","doi-asserted-by":"crossref","first-page":"E8274","DOI":"10.1073\/pnas.1703420114","volume":"114","author":"I \u00cd\u00f1igo-Marco","year":"2017","unstructured":"\u00cd\u00f1igo-Marco I, Valencia M, Larrea L, Bugallo R, Mart\u00ednez-goikoetxea M, Zuriguel I, Arrasate M (2017) E46K \u03b1,-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. Proceedings of the National Academy of Sciences 114(39):E8274\u2013E8283","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6804","key":"2085_CR53","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/35036627","volume":"407","author":"H Jeong","year":"2000","unstructured":"Jeong H, Tombor B, Albert R, Oltvai ZN, Barab\u00e1si A. L. (2000) The large-scale organization of metabolic networks. Nature 407(6804):651","journal-title":"Nature"},{"issue":"9","key":"2085_CR54","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn S, Drolet RE, Cramer PE, Wong AHK, Toolan DM, Gretzula CA, Voleti B, Vassileva G, et al. (2017) TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation. Proceedings of the National Academy of Sciences 114(9):2389\u20132394","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"2085_CR55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1749-8104-6-22","volume":"6","author":"P Joset","year":"2011","unstructured":"Joset P, Wacker A, Babey R, Ingold EA, Andermatt I, Stoeckli ET, Gesemann M (2011) Rostral growth of commissural axons requires the cell adhesion molecule MDGA2. Neural development 6(1):22","journal-title":"Neural development"},{"issue":"6","key":"2085_CR56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T (2017) Striatal dopamine in P arkinson disease: a meta-analysis of imaging studies. Annals of neurology 82(6):873\u2013882","journal-title":"Annals of neurology"},{"issue":"2","key":"2085_CR57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.22630","volume":"71","author":"A Kachroo","year":"2012","unstructured":"Kachroo A, Schwarzschild MA (2012) Adenosine A2A receptor gene disruption protects in an \u03b1-synuclein model of Parkinson\u2019s disease. Annals of neurology 71(2):278\u2013282","journal-title":"Annals of neurology"},{"issue":"1","key":"2085_CR58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-007-0302-x","volume":"115","author":"PJ Kahle","year":"2008","unstructured":"Kahle PJ (2008) \u03b1-synucleinopathy models and human neuropathology: similarities and differences. Acta neuropathologica 115(1):87\u201395","journal-title":"Acta neuropathologica"},{"issue":"6","key":"2085_CR59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","volume":"28","author":"M Kasten","year":"2013","unstructured":"Kasten M, Klein C (2013) The many faces of alpha-synuclein mutations. Mov Disord 28 (6):697\u2013701","journal-title":"Mov Disord"},{"issue":"3","key":"2085_CR60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","volume":"25","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann A, Gentleman R, Huber W (2008) Arrayqualitymetrics\u2014a bioconductor package for quality assessment of microarray data. Bioinformatics 25(3):415\u2013416","journal-title":"Bioinformatics"},{"issue":"1","key":"2085_CR61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13041-019-0436-5","volume":"12","author":"J Kelly","year":"2019","unstructured":"Kelly J, Moyeed R, Carroll C, Albani D, Li X (2019) Gene expression meta-analysis of Parkinson\u2019s disease and its relationship with Alzheimer\u2019s disease. Molecular brain 12(1):16","journal-title":"Molecular brain"},{"issue":"4","key":"2085_CR62","first-page":"729","volume":"26","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Deng HX, Wong YC, Siddique T, Krainc D (2017) The Parkinson\u2019s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking. Human molecular genetics 26(4):729\u2013741","journal-title":"Human molecular genetics"},{"issue":"8","key":"2085_CR63","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136(8):2419\u20132431","journal-title":"Brain"},{"issue":"4","key":"2085_CR64","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","volume":"14","author":"K Krieglstein","year":"1995","unstructured":"Krieglstein K, Suter-Crazzolara C, Fischer W, Unsicker K (1995) TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. The EMBO journal 14(4):736\u2013742","journal-title":"The EMBO journal"},{"issue":"5","key":"2085_CR65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1084\/jem.20050163","volume":"202","author":"AM Landau","year":"2005","unstructured":"Landau AM, Luk KC, Jones ML, Siegrist-Johnstone R, Young YK, Kouassi E, Rymar VV, Dagher A, et al. (2005) Defective Fas expression exacerbates neurotoxicity in a model of Parkinson\u2019s disease. J Exp Med 202(5):575\u2013581","journal-title":"J Exp Med"},{"issue":"1","key":"2085_CR66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2350-10-98","volume":"10","author":"JC Latourelle","year":"2009","unstructured":"Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, et al. (2009) Genomewide association study for onset age in Parkinson disease. BMC medical genetics 10(1):98","journal-title":"BMC medical genetics"},{"key":"2085_CR67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/bs.pmbts.2017.12.009","volume":"156","author":"RW Ledeen","year":"2018","unstructured":"Ledeen RW, Wu G (2018) Gangliosides, \u03b1-synuclein, and Parkinson\u2019s Disease. Progress in molecular biology and translational science 156:435\u2013454","journal-title":"Progress in molecular biology and translational science"},{"issue":"6","key":"2085_CR68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee TI, Young RA (2013) Transcriptional regulation and its misregulation in disease. Cell 152(6):1237\u20131251","journal-title":"Cell"},{"key":"2085_CR69","first-page":"946813","volume":"2012","author":"IVDA Lima","year":"2012","unstructured":"Lima IVDA, Bastos LFS, Limbor\u010bo-Filho M, Fiebich BL, de Oliveira ACP (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators of inflammation 2012:946813","journal-title":"Mediators of inflammation"},{"key":"2085_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00453-0","volume":"308","author":"J Liu","year":"2003","unstructured":"Liu J, Cavalli LR, Haddad BR, Papadopoulos V (2003) Molecular cloning, genomic organization, chromosomal mapping and subcellular localization of mouse PAP7: a PBR and PKA-RI\u03b1 associated protein. Gene 308:1\u201310","journal-title":"Gene"},{"issue":"8","key":"2085_CR71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/mds.27061","volume":"32","author":"W Mandemakers","year":"2017","unstructured":"Mandemakers W, Quadri M, Stamelou M, Bonifati V (2017) TMEM230: How Does it fit in the etiology and pathogenesis of Parkinson\u2019s disease? Mov Disord 32(8):1159\u20131162","journal-title":"Mov Disord"},{"issue":"2","key":"2085_CR72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bib\/bbw114","volume":"19","author":"C Manzoni","year":"2018","unstructured":"Manzoni C, Kia DA, Vandrovcova J, Hardy J, Wood NW, Lewis PA, Ferrari R (2018) Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Briefings in bioinformatics 19(2):286\u2013302","journal-title":"Briefings in bioinformatics"},{"issue":"27","key":"2085_CR73","doi-asserted-by":"crossref","first-page":"10,189","DOI":"10.1073\/pnas.0403661101","volume":"101","author":"D Marazziti","year":"2004","unstructured":"Marazziti D, Golini E, Mandillo S, Magrelli A, Witke W, Matteoni R, Tocchini-Valentini GP (2004) Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson\u2019s disease-associated GPR37\/parkin-associated endothelin-like receptor. Proceedings of the National Academy of Sciences 101(27):10,189\u201310,194","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2085_CR74","doi-asserted-by":"crossref","unstructured":"Marchetti B, Tirolo C, L\u2019Episcopo F, Caniglia S, Testa N, Smith JA, Pluchino S, Serapide MF (2020) Parkinson\u2019s disease, aging and adult neurogenesis: Wnt\/\u03b2-catenin signalling as the key to unlock the mystery of endogenous brain repair. Aging Cell, p e13101","DOI":"10.1111\/acel.13101"},{"issue":"9","key":"2085_CR75","doi-asserted-by":"crossref","first-page":"e0161,567","DOI":"10.1371\/journal.pone.0161567","volume":"11","author":"E Mariani","year":"2016","unstructured":"Mariani E, Frabetti F, Tarozzi A, Pelleri MC, Pizzetti F, Casadei R (2016) Meta-analysis of Parkinson\u2019s disease transcriptome data using TRAM software: whole substantia Nigra tissue and single dopamine neuron differential gene expression. PLoS One 11(9):e0161,567","journal-title":"PLoS One"},{"issue":"1","key":"2085_CR76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-016-0540-8","volume":"13","author":"AC Martini","year":"2016","unstructured":"Martini AC, Berta T, Forner S, Chen G, Bento AF, Ji RR, Rae GA (2016) Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. Journal of neuroinflammation 13(1):75","journal-title":"Journal of neuroinflammation"},{"issue":"5456","key":"2085_CR77","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, et al. (2000) Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders. Science 287(5456):1265\u20131269","journal-title":"Science"},{"issue":"4","key":"2085_CR78","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675\u2013691","journal-title":"Neuron"},{"key":"2085_CR79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncir.2014.00021","volume":"8","author":"C Miguelez","year":"2014","unstructured":"Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L (2014) Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson\u2019s disease. Frontiers in neural circuits 8:21","journal-title":"Frontiers in neural circuits"},{"issue":"16","key":"2085_CR80","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/mds.23388","volume":"25","author":"IN Miller","year":"2010","unstructured":"Miller IN, Cronin-Golomb A (2010) Gender differences in Parkinson\u2019s disease: clinical characteristics and cognition. Movement disorders 25(16):2695\u20132703","journal-title":"Movement disorders"},{"issue":"1","key":"2085_CR81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.expneurol.2006.12.005","volume":"204","author":"RM Miller","year":"2007","unstructured":"Miller RM, Kiser GL, Kaysser-Kranich T, Casaceli C, Colla E, Lee MK, Palaniappan C, Federoff HJ (2007) Wild-type and mutant \u03b1-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Experimental neurology 204(1):421\u2013432","journal-title":"Experimental neurology"},{"issue":"1","key":"2085_CR82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00439-008-0525-5","volume":"124","author":"I Mizuta","year":"2008","unstructured":"Mizuta I, Tsunoda T, Satake W, Nakabayashi Y, Watanabe M, Takeda A, Hasegawa K, Nakashima K, et al. (2008) Calbindin 1, fibroblast growth factor 20, and \u03b1-synuclein in sporadic Parkinson\u2019s disease. Human genetics 124(1):89","journal-title":"Human genetics"},{"issue":"1","key":"2085_CR83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-7-26","volume":"7","author":"L Molochnikov","year":"2012","unstructured":"Molochnikov L, Rabey JM, Dobronevsky E, Bonuccelli U, Ceravolo R, Frosini D, Gr\u00fcnblatt E., Riederer P, et al. (2012) A molecular signature in blood identifies early Parkinson\u2019s disease. Molecular neurodegeneration 7(1):26","journal-title":"Molecular neurodegeneration"},{"issue":"12","key":"2085_CR84","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, et al. (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. The Lancet Neurology 18(12):1091\u2013 1102","journal-title":"The Lancet Neurology"},{"key":"2085_CR85","doi-asserted-by":"crossref","unstructured":"Nam GE, Kim SM, Han K, Kim NH, Chung HS, Kim JW, Han B, Cho SJ, et al. (2018) Metabolic syndrome and risk of Parkinson disease: a nationwide cohort study, PLos medicine 15(8):e1002640","DOI":"10.1371\/journal.pmed.1002640"},{"issue":"S3","key":"2085_CR86","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1002\/mds.22062","volume":"23","author":"JA Obeso","year":"2008","unstructured":"Obeso JA, Rodr\u00edguez-oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M (2008) Functional organization of the basal ganglia: therapeutic implications for Parkinson\u2019s disease. Movement disorders: Official journal of the Movement Disorder Society 23(S3):S548\u2013S559","journal-title":"Movement disorders: Official journal of the Movement Disorder Society"},{"key":"2085_CR87","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2016.11.022","volume":"600","author":"V Paban","year":"2017","unstructured":"Paban V, Loriod B, Villard C, Buee L, Blum D, Pietropaolo S, Cho YH, Gory-Faure S, et al. (2017) Omics analysis of mouse brain models of human diseases. Gene 600:90\u2013100","journal-title":"Gene"},{"key":"2085_CR88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.nbd.2018.08.001","volume":"119","author":"I Paiva","year":"2018","unstructured":"Paiva I, Jain G, L\u00e1zaro D. F., Jer\u010di\u0107 KG, Hentrich T, Kerimoglu C, Pinho R, Szego\u0307 \u00c9M, et al. (2018) Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of disease 119:121\u2013135","journal-title":"Neurobiology of disease"},{"issue":"12","key":"2085_CR89","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Sch\u00fctz AL, Rajput A, Szego\u0307 \u00c9M, et al. (2017) Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Human molecular genetics 26(12):2231\u20132246","journal-title":"Human molecular genetics"},{"issue":"6","key":"2085_CR90","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygeno.2012.08.003","volume":"100","author":"SR Piccolo","year":"2012","unstructured":"Piccolo SR, Sun Y, Campbell JD, Lenburg ME, Bild AH, Johnson WE (2012) A single-sample microarray normalization method to facilitate personalized-medicine workflows. Genomics 100 (6):337\u2013344","journal-title":"Genomics"},{"issue":"8","key":"2085_CR91","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00415-016-8384-9","volume":"264","author":"M Picillo","year":"2017","unstructured":"Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT (2017) The relevance of gender in Parkinson\u2019s disease: a review. Journal of neurology 264(8):1583\u20131607","journal-title":"Journal of neurology"},{"issue":"10","key":"2085_CR92","doi-asserted-by":"crossref","first-page":"e1002,931","DOI":"10.1371\/journal.pmed.1002931","volume":"16","author":"M Posavi","year":"2019","unstructured":"Posavi M, Diaz-Ortiz M, Liu B, Swanson CR, Skrinak RT, Hernandez-Con P, Amado DA, Fullard M, et al. (2019) Characterization of Parkinson\u2019s disease using blood-based biomarkers: a multicohort proteomic analysis. PLoS medicine 16(10):e1002,931","journal-title":"PLoS medicine"},{"issue":"13","key":"2085_CR93","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Movement disorders 29(13):1583\u20131590","journal-title":"Movement disorders"},{"issue":"34","key":"2085_CR94","doi-asserted-by":"crossref","first-page":"26,515","DOI":"10.1074\/jbc.M003542200","volume":"275","author":"AN Pronin","year":"2000","unstructured":"Pronin AN, Morris AJ, Surguchov A, Benovic JL (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. Journal of Biological Chemistry 275(34):26,515\u201326,522","journal-title":"Journal of Biological Chemistry"},{"issue":"18","key":"2085_CR95","doi-asserted-by":"crossref","first-page":"10,914","DOI":"10.1073\/pnas.95.18.10914","volume":"95","author":"J Raber","year":"1998","unstructured":"Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L (1998) Isoform-specific effects of human Apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proceedings of the National Academy of Sciences 95(18):10,914\u201310,919","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6776","key":"2085_CR96","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/35006165","volume":"404","author":"J Raber","year":"2000","unstructured":"Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, Mucke L (2000) Apolipoprotein E and cognitive performance. Nature 404(6776):352\u2013354","journal-title":"Nature"},{"issue":"7","key":"2085_CR97","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research 43 (7):e47","journal-title":"Nucleic acids research"},{"issue":"2","key":"2085_CR98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nbd.2004.03.006","volume":"16","author":"E Roussa","year":"2004","unstructured":"Roussa E, Farkas LM, Krieglstein K (2004) TGF-\u03b2 promotes survival on mesencephalic dopaminergic neurons in cooperation with Shh and FGF-8. Neurobiology of disease 16(2):300\u2013310","journal-title":"Neurobiology of disease"},{"issue":"11","key":"2085_CR99","doi-asserted-by":"crossref","first-page":"e0142,582","DOI":"10.1371\/journal.pone.0142582","volume":"10","author":"JA Santiago","year":"2015","unstructured":"Santiago JA, Potashkin JA (2015) Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson\u2019s disease patients. PLoS One 10(11):e0142,582","journal-title":"PLoS One"},{"issue":"3","key":"2085_CR100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bpa.12511","volume":"28","author":"G Santpere","year":"2018","unstructured":"Santpere G, Garcia-Esparcia P, Andres-Benito P, Lorente-Galdos B, Navarro A, Ferrer I (2018) Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with L ewy bodies. Brain Pathol 28(3):315\u2013333","journal-title":"Brain Pathol"},{"issue":"7","key":"2085_CR101","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, et al. (2012) Fiji: an open-source platform for biological-image analysis. Nature methods 9(7):676\u2013682","journal-title":"Nature methods"},{"issue":"10","key":"2085_CR102","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1096\/fasebj.4.10.2197154","volume":"4","author":"P Seeman","year":"1990","unstructured":"Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson\u2019s disease and schizophrenia. The FASEB Journal 4(10):2737\u20132744","journal-title":"The FASEB Journal"},{"issue":"2","key":"2085_CR103","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3892\/mmr.2017.6751","volume":"16","author":"S Shao","year":"2017","unstructured":"Shao S, Wang GL, Raymond C, Deng XH, Zhu XL, Wang D, Hong LP (2017) Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson\u2019s disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3k\/AKt signaling pathway. Molecular medicine reports 16(2):1269\u20131277","journal-title":"Molecular medicine reports"},{"issue":"1","key":"2085_CR104","doi-asserted-by":"crossref","first-page":"e8856","DOI":"10.1371\/journal.pone.0008856","volume":"5","author":"F Simunovic","year":"2010","unstructured":"Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC (2010) Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PloS one 5(1):e8856","journal-title":"PloS one"},{"issue":"1","key":"2085_CR105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3(1):1\u201325","journal-title":"Statistical applications in genetics and molecular biology"},{"key":"2085_CR106","unstructured":"Sonne J, Beato MR (2018) Neuroanatomy, substantia nigra. In: Statpearls [internet]. Statpearls publishing, USA"},{"issue":"16","key":"2085_CR107","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1091\/mbc.e08-03-0302","volume":"20","author":"VL Sousa","year":"2009","unstructured":"Sousa VL, Bellani S, Giannandrea M, Yousuf M, Valtorta F, Meldolesi J, Chieregatti E (2009) \u03b1-Synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Molecular biology of the cell 20(16):3725\u20133739","journal-title":"Molecular biology of the cell"},{"issue":"6645","key":"2085_CR108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"4","key":"2085_CR109","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","volume":"93","author":"K Sriram","year":"2018","unstructured":"Sriram K, Insel PA (2018) G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Molecular pharmacology 93(4):251\u2013258","journal-title":"Molecular pharmacology"},{"key":"2085_CR110","doi-asserted-by":"crossref","first-page":"e31,012","DOI":"10.7554\/eLife.31012","volume":"6","author":"M Steger","year":"2017","unstructured":"Steger M, Diez F, Dhekne HS, Lis P, Nirujogi RS, Karayel O, Tonelli F, Martinez TN, et al. (2017) Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife 6:e31,012","journal-title":"Elife"},{"issue":"14","key":"2085_CR111","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1080\/14656566.2016.1219337","volume":"17","author":"F Stocchi","year":"2016","unstructured":"Stocchi F, Torti M, Fossati C (2016) Advances in dopamine receptor agonists for the treatment of Parkinson\u2019s disease. Expert opinion on pharmacotherapy 17(14):1889\u20131902","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"2","key":"2085_CR112","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/ENDO:29:2:275","volume":"29","author":"A Tam\u00e1s","year":"2006","unstructured":"Tam\u00e1s A., Lubics A, Lengv\u00e1ri I., Reglo\u0307di D. (2006) Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson\u2019s disease. Endocr 29(2):275\u2013287","journal-title":"Endocr"},{"issue":"10","key":"2085_CR113","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ejn.13638","volume":"47","author":"A Tanimura","year":"2018","unstructured":"Tanimura A, Pancani T, Lim SAO, Tubert C, Melendez AE, Shen W, Surmeier DJ (2018) Striatal cholinergic interneurons and Parkinson\u2019s disease. European Journal of Neuroscience 47(10):1148\u20131158","journal-title":"European Journal of Neuroscience"},{"issue":"10","key":"2085_CR114","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/ijms19102852","volume":"19","author":"A Taracha","year":"2018","unstructured":"Taracha A, Kotarba G, Wilanowski T (2018) Neglected functions of TFCP2\/TFCP2l1\/UBP1 transcription factors may offer valuable insights into their mechanisms of action. International journal of molecular sciences 19(10):2852","journal-title":"International journal of molecular sciences"},{"issue":"8","key":"2085_CR115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jnnp.2006.104695","volume":"78","author":"KSM Taylor","year":"2007","unstructured":"Taylor KSM, Cook JA, Counsell CE (2007) Heterogeneity in male to female risk for Parkinson\u2019s disease. Journal of Neurology Neurosurgery & Psychiatry 78(8):905\u2013906","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"},{"issue":"6","key":"2085_CR116","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.conb.2004.10.003","volume":"14","author":"JM Tepper","year":"2004","unstructured":"Tepper JM, Bolam JP (2004) Functional diversity and specificity of neostriatal interneurons. Current opinion in neurobiology 14(6):685\u2013692","journal-title":"Current opinion in neurobiology"},{"issue":"21","key":"2085_CR117","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/bioinformatics\/btn469","volume":"24","author":"Y Tsuruoka","year":"2008","unstructured":"Tsuruoka Y, Tsujii J, Ananiadou S (2008) FACTA: a text search engine for finding associated biomedical concepts. Bioinformatics 24(21):2559\u20132560","journal-title":"Bioinformatics"},{"issue":"23","key":"2085_CR118","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","volume":"294","author":"CL Ugalde","year":"2019","unstructured":"Ugalde CL, Lawson VA, Finkelstein DI, Hill AF (2019) The role of lipids in \u03b1-synuclein misfolding and neurotoxicity. J Biol Chem 294(23):9016\u20139028","journal-title":"J Biol Chem"},{"issue":"5","key":"2085_CR119","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","author":"UniProt Consortium","year":"2018","unstructured":"UniProt Consortium, et al. (2018) Uniprot: the universal protein knowledgebase. Nucleic acids research 46(5):2699","journal-title":"Nucleic acids research"},{"key":"2085_CR120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2018.00112","volume":"12","author":"Z Wassouf","year":"2018","unstructured":"Wassouf Z, Hentrich T, Samer S, Rotermund C, Kahle PJ, Ehrlich I, Riess O, Casadei N, et al. (2018) Environmental enrichment prevents transcriptional disturbances induced by alpha-synuclein overexpression. Frontiers in cellular neuroscience 12:112","journal-title":"Frontiers in cellular neuroscience"},{"issue":"4","key":"2085_CR121","doi-asserted-by":"crossref","first-page":"e60,314","DOI":"10.1371\/journal.pone.0060314","volume":"8","author":"CS Wu","year":"2013","unstructured":"Wu CS, Chen H, Sun H, Zhu J, Jew CP, Wager-Miller J, Straiker A, Spencer C, et al. (2013) GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. PLoS One 8(4):e60,314","journal-title":"PLoS One"},{"issue":"10","key":"2085_CR122","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","volume":"90","author":"G Wu","year":"2012","unstructured":"Wu G, Lu ZH, Kulkarni N, Ledeen RW (2012) Deficiency of ganglioside GM1 correlates with Parkinson\u2019s disease in mice and humans. Journal of neuroscience research 90(10):1997\u20132008","journal-title":"Journal of neuroscience research"},{"issue":"1","key":"2085_CR123","first-page":"22","volume":"68","author":"Y Wu","year":"2011","unstructured":"Wu Y, Le W, Jankovic J (2011) Preclinical biomarkers of Parkinson disease. Archives of neurology 68(1):22\u201330","journal-title":"Archives of neurology"},{"issue":"3","key":"2085_CR124","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nbd.2007.11.008","volume":"29","author":"TA Yacoubian","year":"2008","unstructured":"Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG (2008) Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiology of disease 29(3):515\u2013528","journal-title":"Neurobiology of disease"},{"key":"2085_CR125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A (2018) The role of insulin\/IGF-1\/PI3k\/akt\/GSK3\u03b2 signaling in Parkinson\u2019s disease dementia. Frontiers in neuroscience 12:73","journal-title":"Frontiers in neuroscience"},{"issue":"7","key":"2085_CR126","doi-asserted-by":"crossref","first-page":"e0180,892","DOI":"10.1371\/journal.pone.0180892","volume":"12","author":"Y Yang","year":"2017","unstructured":"Yang Y, Qin M, Bao P, Xu W, Xu J (2017) Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of \u03b1-synuclein via exosome. PloS one 12(7):e0180,892","journal-title":"PloS one"},{"issue":"1","key":"2085_CR127","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/acschemneuro.8b00572","volume":"10","author":"N Ye","year":"2018","unstructured":"Ye N, Li B, Mao Q, Wold EA, Tian S, Allen JA, Zhou J (2018) Orphan receptor GPR88 as an emerging neurotherapeutic target. ACS chemical neuroscience 10(1):190\u2013200","journal-title":"ACS chemical neuroscience"},{"issue":"5","key":"2085_CR128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","volume":"10","author":"SV Zaichick","year":"2017","unstructured":"Zaichick SV, McGrath KM, Caraveo G (2017) The role of Ca2+ signaling in Parkinson\u2019s disease. Disease models & mechanisms 10(5):519\u2013535","journal-title":"Disease models & mechanisms"},{"issue":"3","key":"2085_CR129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.WNL.0000150591.33787.A4","volume":"64","author":"S Zaja-Milatovic","year":"2005","unstructured":"Zaja-Milatovic S, Milatovic D, Schantz A, Zhang J, Montine K, Samii A, Deutch A, Montine T (2005) Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64(3):545\u2013547","journal-title":"Neurology"},{"issue":"2","key":"2085_CR130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban J. C., Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, et al. (2004) The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 55(2):164\u2013173","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"6","key":"2085_CR131","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1354\/vp.42-6-753","volume":"42","author":"C Zeiss","year":"2005","unstructured":"Zeiss C (2005) Neuroanatomical phenotyping in the mouse: the dopaminergic system. Veterinary pathology 42(6):753\u2013773","journal-title":"Veterinary pathology"},{"key":"2085_CR132","doi-asserted-by":"crossref","first-page":"44248","DOI":"10.1038\/srep44248","volume":"7","author":"L Zhang","year":"2017","unstructured":"Zhang L, Okada T, Badawy SMM, Hirai C, Kajimoto T, Nakamura SI (2017) Extracellular \u03b1-synuclein induces sphingosine 1-phosphate receptor subtype 1 uncoupled from inhibitory G-protein leaving \u03b2-arrestin signal intact. Scientific reports 7:44248","journal-title":"Scientific reports"},{"issue":"36","key":"2085_CR133","doi-asserted-by":"crossref","first-page":"11,929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, et al. (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. Journal of Neuroscience 34(36):11,929\u201311,947","journal-title":"Journal of Neuroscience"},{"issue":"18","key":"2085_CR134","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijms20184391","volume":"20","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Fu P, Zhang Z, Lin K, Ko JKS, Yung KKL (2019) Roles of glutamate receptors in Parkinson\u2019s disease. International journal of molecular sciences 20(18):4391","journal-title":"International journal of molecular sciences"},{"issue":"30","key":"2085_CR135","doi-asserted-by":"crossref","first-page":"10,085","DOI":"10.1523\/JNEUROSCI.2156-14.2014","volume":"34","author":"H Zhao","year":"2014","unstructured":"Zhao H, Kim Y, Park J, Park D, Lee SE, Chang I, Chang S (2014) SCAMP5 plays a critical role in synaptic vesicle endocytosis during high neuronal activity. Journal of Neuroscience 34 (30):10,085\u201310,095","journal-title":"Journal of Neuroscience"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02085-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:42:29Z","timestamp":1723682549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02085-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02085-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.04.016642","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of Interest"}},{"value":"All mouse experiments were performed according to the national guidelines of the animal welfare law in Germany (BGBl. I S. 1206, 1313 and BGBl. I S. 1934). The protocol was reviewed and approved by the \u2018Nieders\u00e4chsisches Landesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany\u2019 (Permit Number: 33.9-42502-05-11A193).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The code used for the bioinformatics analyses in this study is available from the LCSB (contact: Enrico Glaab, e-mail: enrico.glaab@uni.lu) on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}